Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
International Journal of Surgery (London, England)|March 11, 2024
Simulation training of laparoscopic biliary-enteric anastomosis with a three-dimensional-printed model leads to better skill transfer: a randomized controlled trialJiliang Shen, Yaping Zhang, Bin Zhang, et al.Oncotarget|April 7, 2016
TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growthJiliang Shen, Hui Lin, Gonghui Li, et al.Cell Death & Disease|November 17, 2017
Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinomaLiang Shi, Peijian Yan, Yuelong Liang, et al.Cancer Medicine|May 27, 2016
Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapyJiliang Shen, Yaping Zhang, Hong Yu, et al.Oncotarget|January 28, 2017
DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancerJiliang Shen, Senjun Zhou, Liang Shi, et al.Scientific Reports|January 20, 2026
Surgical resection versus non-surgical treatments for hepatocellular carcinoma with macrovascular invasionYifeng Fang, Enjie Zhou, Jiahao Hu, et al.Frontiers in Oncology|January 28, 2021
Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After SurgeryMingyu Chen, Shijie Li, Win Topatana, et al.Cancer Letters|January 26, 2016
Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signalsLiang Shi, Hui Lin, Gonghui Li, et al.Plos One|November 18, 2014
Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysisJiang Chen, Jinghua Liu, Renan Jin, et al.Pharmaceutics|March 27, 2025
Altered Pharmacokinetics of Ropivacaine in Patients Undergoing Laparoscopic Major HepatectomyJun Zhang, Hongyuan Lv, Jiliang Shen, et al.Pageof 5